Latest Articlesddd
Sanofi and AstraZeneca MELODY Trial Results for Nirsevimab In March 2017, Sanofi (SNY) and AstraZeneca (
Vertex and CRISPR Granted PRIME Designation from the EMA for CTX001 Vertex Pharmaceuticals (VRTX) and CRISPR Therapeutics …
Prohost Portfolio PLUS #4 Celldex Therapeutics Celldex Therapeutics (CLDX) stock is gaining momentum. On April 12, …
Gilead Sciences and Eisai Pharmaceutical Co Submitted an Application to Japan's PMDA for Filgotinib Galapagos NV …
European Authorities Recommended Additional Approval of Bristol-Myers Squibb Product Onureg® for AML Bristol-Myers Squibb (BMY): The …
Humanigen Product Lenzilumab Combination with CAR-T At the recommended Phase 2 dose, lenzilumab in combination with …
Cassava Sciences Guidance and Financial Results Cassava Sciences (SAVA) announced financial results for the first quarter …
Vir Biotechnology and GlaxoSmithKline in April 2020 In April 2020, Vir Biotechnology and GlaxoSmithKline entered into …
Amylyx Pharmaceuticals Updated Plans to Advance AMX0035 Amylyx Pharmaceuticals, Inc. provided an update on its plans …
Prohost Portfolio PLUS #3 CureVac N.V. We were looking forward to learning more important details about …
Inovio Pharmaceuticals Promising Results for INO-4800 for COVID-19 Inovio Pharmaceuticals (INO) announces promising results of a …
FDA Grants Accelerated Approval for Gilead Sciences Trodelvy® The United States Food and Drug Administration (FDA) …
vTv Therapeutics Receives Breakthrough Therapy Designation for TTP399 vTv Therapeutics (VTVT) - a clinical-stage biopharmaceutical company …
Prohost Portfolio PLUS #2 Re-Working Some Evaluated Biotechnology Firms Exelixis: 2020 and 2021 Wondering why Exelixis’ …
Gilead Sciences is Granted FDA Approval for Trodelvy® Gilead Sciences (GILD), a company that has been …
Exelixis Latest News The latest news announced by Exelixis (EXEL) is the FDA acceptance of its …
Intellia Therapeutics NTLA-2001 for ATTR Granted Orphan Drug Designation by the EC Intellia Therapeutics (NTLA) announced …
Exelixis Boxed in on Good News Exelixis (EXEL) is one of the firms boxed in by …
Illumina Acquisition of GRAIL On September 21, 2020, Illumina and GRAIL Inc. announced that they entered into …
Rubius Therapeutics Finding small development-stage biotech firms that contribute to biotechnology's limitless revolution of the biological …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
